CD 130 (Ranitidine hydrochloride 300 mg)
Pill imprint CD 130 has been identified as Ranitidine hydrochloride 300 mg.
Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; zollinger-ellison syndrome; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- CD 130
- 300 mg
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- magnesium stearate
sodium starch glycolate type A potato
ferric oxide red
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|49884-0648||Par Pharmaceutical, Inc.|
Note: Inactive ingredients may vary.
More about ranitidine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.